Biopince
Payments companies reported to CMS as associated with Biopince. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Biopince, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Biopince
These are the largest totals companies reported as associated with Biopince. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joshua Dowell | Indianapolis, IN | Diagnostic Radiology | $53.24 |
| Vincent Flanders | Carmel, IN | Diagnostic Radiology | $53.24 |
| Frederic Bertino | New York, NY | Vascular & Interventional Radiology | $30.66 |
| Michael Muhlert | Memphis, TN | Vascular & Interventional Radiology | $24.88 |
| Stephen Seedial | Ypsilanti, MI | Diagnostic Radiology | $19.81 |
| Joseph Triolo | Toms River, NJ | Diagnostic Radiology | $18.70 |
| Philip Murillo | Toms River, NJ | Diagnostic Radiology | $18.70 |
| Jeffrey Critchfield | Detroit, MI | Vascular & Interventional Radiology | $18.48 |
| Michael Trpkovski | Clinton Township, MI | Vascular & Interventional Radiology | $18.40 |
| Nishad Nadkarni | Waterloo, IA | Vascular & Interventional Radiology | $18.14 |
Prescribed Biopince?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.